The potential for PCR based testing to improve diagnosis and treatment of sepsis.
about
The IRIDICA BAC BSI Assay: Rapid, Sensitive and Culture-Independent Identification of Bacteria and Candida in BloodBarriers to the effective treatment of sepsis: antimicrobial agents, sepsis definitions, and host-directed therapies.PCSK9 is a critical regulator of the innate immune response and septic shock outcome.Sepsis outside intensive care unit: the other side of the coin.Rapid diagnosis of bloodstream infections in the critically ill: Evaluation of the broad-range PCR/ESI-MS technology.
P2860
The potential for PCR based testing to improve diagnosis and treatment of sepsis.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
The potential for PCR based testing to improve diagnosis and treatment of sepsis.
@en
The potential for PCR based testing to improve diagnosis and treatment of sepsis.
@nl
type
label
The potential for PCR based testing to improve diagnosis and treatment of sepsis.
@en
The potential for PCR based testing to improve diagnosis and treatment of sepsis.
@nl
prefLabel
The potential for PCR based testing to improve diagnosis and treatment of sepsis.
@en
The potential for PCR based testing to improve diagnosis and treatment of sepsis.
@nl
P2860
P1476
The potential for PCR based testing to improve diagnosis and treatment of sepsis.
@en
P2093
P2860
P304
P356
10.1007/S11908-013-0350-4
P577
2013-10-01T00:00:00Z